Northern Trust’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Northern Trust’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,659	Closed	-$99.7K	–	4529
2023 Q4	$99.7K	Hold	15,659	–	–	﹤0.01%	4115
2023 Q3	$67.3K	Hold	15,659	–	–	﹤0.01%	4098
2023 Q2	$40.4K	Buy	+15,659	New	+$61.8K	﹤0.01%	4270

Northern Trust's FRLN Position: Q1 2024 in Review

Northern Trust sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2024, closing a stake of 15,659 shares — an estimated $99.7K sold.

Northern Trust first reported a position in FRLN in Q2 2023 and held it in 3 quarters. The position peaked at $99.7K in Q4 2023. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

Northern Trust reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Northern Trust sold 15,659 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2024, an estimated $99.7K.
Northern Trust first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q2 2023 and held it in 3 quarters.
Northern Trust's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $99.7K in Q4 2023.
0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.